stockrow
Saturday 31 October 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
19.74
0.13
+0.66%
Follow SBRA
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
75.04 | 30.05 | 29.14 | 25.19 |
+8 more quarters Free account |
P/S ratio |
5.73 | 5.96 | 5.90 | 6.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 60.24 | |
P/Operating CF |
57.35 | 49.29 | 52.28 | 44.73 | |
P/B ratio |
1.79 | 1.74 | 1.62 | 1.58 | |
Price to Tangible BV |
1.84 | 1.78 | 1.66 | 1.62 | |
EV/Sales |
8.50 | 9.09 | 9.06 | 9.20 | |
EV/EBITDA |
19.96 | 16.30 | 15.83 | 15.66 | |
EV/Operating CF |
19.67 | 20.15 | 20.14 | 20.09 | |
EV/FCF |
(26.37) | (56.23) | (122.74) | 92.36 | |
Quick Ratio |
2.07 | 1.05 | 0.65 | 1.67 | |
Current Ratio |
3.07 | 4.72 | 4.29 | 5.19 | |
Net Debt/EBITDA |
98.14 | 21.00 | 21.25 | 22.60 | |
Debt/Assets |
47.64% | 47.67% | 46.04% | 46.56% | |
Debt/Equity |
0.95 | 0.96 | 0.90 | 0.92 | |
Asset Turnover |
0.16 | 0.15 | 0.14 | 0.14 | |
Operating CF/Net income |
(3.41) | 2.41 | 3.21 | 4.44 | |
Capex/Depreciation |
(3.72) | (2.03) | (2.40) | (4.29) | |
Interest Coverage |
(1.08) | 2.39 | 2.21 | 1.97 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.13% | 6.70% | 7.51% | 6.61% | |
Intangible Assets out of Total Assets |
0.02 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
1.73% | 1.40% | 1.45% | 1.51% | |
Graham Net Nets |
(0.49) | (0.46) | (0.47) | (0.47) | |
Graham Number |
7.99 | 12.62 | 13.08 | 14.01 | |
Earnings Yield |
1.33% | 3.33% | 3.43% | 3.97% | |
Free Cash Flow Yield |
(5.63%) | (2.71%) | (1.25%) | 1.66% | |
Revenue per Share |
0.94 | 0.88 | 0.88 | 0.79 | |
Operating CF per Share |
0.34 | 0.39 | 0.36 | 0.42 | |
Capex per Share |
(0.83) | (0.43) | (0.51) | (0.87) | |
Free Cash Flow per Share |
(0.49) | (0.04) | (0.15) | (0.45) | |
Cash per Share |
0.94 | 0.49 | 0.32 | 0.87 | |
Shareholders Equity per Share |
10.91 | 11.06 | 11.70 | 11.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.91 | 11.06 | 11.70 | 11.78 | |
Free Cash Flow |
(123.92) | (9.59) | (35.73) | (107.99) | |
Working Capital |
238.47 | 438.41 | 392.91 | 520.00 | |
Capital Expenditures |
(209.74) | (107.95) | (123.16) | (207.95) | |
Net Current Asset Value |
(2,406.75) | (2,246.92) | (2,157.37) | (2,093.78) | |
EV/EBIT |
46.63 | 28.77 | 27.37 | 26.38 | |
Capex to Sales |
0.89 | 0.49 | 0.58 | 1.09 | |
Price to Operating Income |
31.40 | 18.88 | 17.82 | 17.20 | |
| Other line items | |||||
Average Payables |
114.01 | 115.01 | 118.61 | 123.42 | |
Average Assets |
5,420.30 | 5,412.19 | 5,398.54 | 5,465.45 | |
Average Common Equity |
2,731.96 | 2,745.07 | 2,782.54 | 2,785.90 |
Columns are period end dates